Cinemark Holdings, Inc. (NYSE:CNK - Free Report) - Investment analysts at Wedbush cut their Q2 2025 earnings per share estimates for shares of Cinemark in a research note issued on Friday, November 1st. Wedbush analyst A. Reese now anticipates that the company will post earnings of $0.38 per share for the quarter, down from their prior estimate of $0.43. Wedbush currently has a "Hold" rating on the stock. The consensus estimate for Cinemark's current full-year earnings is $1.47 per share. Wedbush also issued estimates for Cinemark's FY2025 earnings at $1.70 EPS and FY2026 earnings at $2.00 EPS.
Cinemark (NYSE:CNK - Get Free Report) last released its quarterly earnings results on Thursday, October 31st. The company reported $1.19 EPS for the quarter, topping the consensus estimate of $0.58 by $0.61. Cinemark had a return on equity of 60.21% and a net margin of 8.36%. The firm had revenue of $921.80 million for the quarter, compared to analyst estimates of $894.90 million. During the same period in the previous year, the company posted $0.61 EPS. Cinemark's revenue for the quarter was up 5.4% on a year-over-year basis.
A number of other equities analysts have also commented on CNK. Macquarie boosted their price objective on shares of Cinemark from $32.00 to $34.00 and gave the stock an "outperform" rating in a report on Friday. B. Riley lowered shares of Cinemark from a "buy" rating to a "neutral" rating and set a $31.00 price objective for the company. in a report on Tuesday, August 27th. JPMorgan Chase & Co. upped their target price on shares of Cinemark from $25.00 to $29.00 and gave the company a "neutral" rating in a research note on Monday, October 14th. Wells Fargo & Company boosted their price objective on Cinemark from $31.00 to $35.00 and gave the company an "overweight" rating in a report on Friday. Finally, The Goldman Sachs Group increased their target price on Cinemark from $16.00 to $20.00 and gave the stock a "sell" rating in a report on Thursday, September 19th. Two analysts have rated the stock with a sell rating, three have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $30.80.
Read Our Latest Stock Analysis on CNK
Cinemark Stock Down 0.9 %
Shares of NYSE CNK traded down $0.28 during trading on Monday, reaching $29.57. 2,005,743 shares of the stock were exchanged, compared to its average volume of 2,859,561. The company has a market capitalization of $3.62 billion, a price-to-earnings ratio of 19.16, a price-to-earnings-growth ratio of 2.02 and a beta of 2.35. The business's 50-day moving average price is $28.24 and its 200 day moving average price is $23.23. The company has a quick ratio of 1.26, a current ratio of 1.29 and a debt-to-equity ratio of 4.11. Cinemark has a twelve month low of $13.19 and a twelve month high of $31.09.
Insider Activity at Cinemark
In other news, insider Valmir Fernandes sold 25,000 shares of the business's stock in a transaction on Monday, August 19th. The shares were sold at an average price of $27.19, for a total transaction of $679,750.00. Following the completion of the transaction, the insider now owns 204,729 shares of the company's stock, valued at approximately $5,566,581.51. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 2.30% of the company's stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Sei Investments Co. raised its stake in shares of Cinemark by 38.1% in the 1st quarter. Sei Investments Co. now owns 115,124 shares of the company's stock worth $2,069,000 after buying an additional 31,739 shares in the last quarter. PEAK6 Investments LLC bought a new position in shares of Cinemark during the 1st quarter valued at about $2,274,000. Barrow Hanley Mewhinney & Strauss LLC grew its stake in shares of Cinemark by 18.1% in the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 676,652 shares of the company's stock worth $14,629,000 after purchasing an additional 103,875 shares during the last quarter. US Bancorp DE grew its stake in shares of Cinemark by 68.8% in the 1st quarter. US Bancorp DE now owns 34,846 shares of the company's stock worth $626,000 after purchasing an additional 14,200 shares during the last quarter. Finally, Maverick Capital Ltd. bought a new stake in shares of Cinemark in the 2nd quarter worth approximately $2,253,000.
About Cinemark
(
Get Free Report)
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.
Featured Stories
Before you consider Cinemark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cinemark wasn't on the list.
While Cinemark currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.